[en] Several tumor necrosis factor receptor (TNFR) family members activate both the classical and the alternative NF-κB pathways. However, how a single receptor engages these two distinct pathways is still poorly understood. Using lymphotoxin β receptor (LTβR) as a prototype, we showed that activation of the alternative, but not the classical, NF-κB pathway relied on internalization of the receptor. Further molecular analyses revealed a specific cytosolic region of LTβR essential for its internalization, TRAF3 recruitment, and p100 processing. Interestingly, we found that dynamin-dependent, but clathrin-independent, internalization of LTβR appeared to be required for the activation of the alternative, but not the classical, NF-κB pathway. In vivo, ligand-induced internalization of LTβR in mesenteric lymph node stromal cells correlated with induction of alternative NF-κB target genes. Thus, our data shed light on LTβR cellular trafficking as a process required for specific biological functions of NF-κB.
Annunziata, C. M., et al. 2007. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 12:115-130.
Batten, M., et al. 2004. TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma. J. Immunol. 172:812-822.
Benezech, C., et al. 2010. Ontogeny of stromal organizer cells during lymph node development. J. Immunol. 184:4521-4530.
Bista, P., et al. 2010. TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor. J. Biol. Chem. 285: 12971-12978.
Cheung, T. C., et al. 2009. Unconventional ligand activation of herpesvirus entry mediator signals cell survival. Proc. Natl. Acad. Sci. U. S. A. 106:6244-6249.
Chung, J. Y., Y. C. Park, H. Ye, and H. Wu. 2002. All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J. Cell Sci. 115:679-688.
Claudio, E., K. Brown, S. Park, H. Wang, and U. Siebenlist. 2002. BAFFinduced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat. Immunol. 3:958-965.
Dejardin, E. 2006. The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development. Biochem. Pharmacol. 72:1161-1179.
Dejardin, E., et al. 2002. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17:525-535.
Delhase, M., M. Hayakawa, Y. Chen, and M. Karin. 1999. Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 284:309-313.
Dempsey, P. W., S. E. Doyle, J. Q. He, and G. Cheng. 2003. The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev. 14:193-209.
Dhawan, P., et al. 2008. The lymphotoxin-beta receptor is an upstream activator of NF-kappaB-mediated transcription in melanoma cells. J. Biol. Chem. 283:15399-15408.
Dougall, W. C., et al. 1999. RANK is essential for osteoclast and lymph node development. Genes Dev. 13:2412-2424.
Force, W. R., et al. 2000. Discrete signaling regions in the lymphotoxin-beta receptor for tumor necrosis factor receptor-associated factor binding, subcellular localization, and activation of cell death and NF-kappaB pathways. J. Biol. Chem. 275:11121-11129.
Futterer, A., K. Mink, A. Luz, M. H. Kosco-Vilbois, and K. Pfeffer. 1998. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 9:59-70.
Grech, A. P., et al. 2005. Tumor necrosis factor receptor 2 (TNFR2) signaling is negatively regulated by a novel, carboxyl-terminal TNFR-associated factor 2 (TRAF2)-binding site. J. Biol. Chem. 280:31572-31581.
Hauer, J., et al. 2005. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs. Proc. Natl. Acad. Sci. U. S. A. 102:2874-2879.
Haybaeck, J., et al. 2009. A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell 16:295-308.
He, J. Q., S. K. Saha, J. R. Kang, B. Zarnegar, and G. Cheng. 2007. Specificity of TRAF3 in its negative regulation of the noncanonical NFkappa B pathway. J. Biol. Chem. 282:3688-3694.
Hehlgans, T., and K. Pfeffer. 2005. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 115:1-20.
Hostager, B. S., S. A. Haxhinasto, S. L. Rowland, and G. A. Bishop. 2003. Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling. J. Biol. Chem. 278:45382-45390.
Iwai, K., and F. Tokunaga. 2009. Linear polyubiquitination: a new regulator of NF-kappaB activation. EMBO Rep. 10:706-713.
Kabashima, K., et al. 2005. Intrinsic lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue dendritic cells. Immunity 22:439-450.
Kagan, J. C., et al. 2008. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat. Immunol. 9:361-368.
Kaisho, T., et al. 2001. IkappaB kinase alpha is essential for mature B cell development and function. J. Exp. Med. 193:417-426.
Keats, J. J., et al. 2007. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 12:131-144.
Kelly, B. T., et al. 2008. A structural explanation for the binding of endocytic dileucine motifs by the AP2 complex. Nature 456:976-979.
Khare, S. D., et al. 2000. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 97:3370-3375.
Li, C., et al. 2003. Structurally distinct recognition motifs in lymphotoxinbeta receptor and CD40 for tumor necrosis factor receptor-associated factor (TRAF)-mediated signaling. J. Biol. Chem. 278:50523-50529.
Liao, G., M. Zhang, E. W. Harhaj, and S. C. Sun. 2004. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J. Biol. Chem. 279:26243-26250.
Lin-Lee, Y. C., et al. 2006. Nuclear localization in the biology of the CD40 receptor in normal and neoplastic human B lymphocytes. J. Biol. Chem. 281:18878-18887.
Macia, E., et al. 2006. Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell 10:839-850.
Marsters, S. A., et al. 1997. Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NFkappaB and AP-1. J. Biol. Chem. 272:14029-14032.
Matsuzawa, A., et al. 2008. Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex. Science 321:663-668.
Moore, C. R., and G. A. Bishop. 2005. Differential regulation of CD40-mediated TNF receptor-associated factor degradation in B lymphocytes. J. Immunol. 175:3780-3789.
Motley, A., N. A. Bright, M. N. Seaman, and M. S. Robinson. 2003. Clathrinmediated endocytosis in AP-2-depleted cells. J. Cell Biol. 162:909-918.
Natoli, G., S. Saccani, D. Bosisio, and I. Marazzi. 2005. Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time. Nat. Immunol. 6:439-445.
Park, Y. C., et al. 2000. A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD-TRAF2 interaction. Cell 101:777-787.
Pasparakis, M. 2009. Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nat. Rev. Immunol. 9:778-788.
Phan, T. G., J. A. Green, E. E. Gray, Y. Xu, and J. G. Cyster. 2009. Immune complex relay by subcapsular sinus macrophages and noncognate B cells drives antibody affinity maturation. Nat. Immunol. 10:786-793.
Sanjo, H., D. M. Zajonc, R. Braden, P. S. Norris, and C. F. Ware. 2010. Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor. J. Biol. Chem. 285:17148-17155.
Sasaki, Y., et al. 2008. NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF: BAFF-R-mediated survival signals in B cells. Proc. Natl. Acad. Sci. U. S. A. 105:10883-10888.
Schneider-Brachert, W., et al. 2004. Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity 21:415-428.
Schutze, S., V. Tchikov, and W. Schneider-Brachert. 2008. Regulation of TNFR1 and CD95 signalling by receptor compartmentalization. Nat. Rev. Mol. Cell Bol. 9:655-662.
Sen, R. 2006. Control of B lymphocyte apoptosis by the transcription factor NF-kappaB. Immunity 25:871-883.
Senftleben, U., et al. 2001. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293:1495-1499.
Shinkura, R., et al. 1999. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase. Nat. Genet. 22:74-77.
Silke, J., and R. Brink. 2010. Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs. Cell Death Differ. 17:35-45.
Thompson, J. S., et al. 2001. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293:2108-2111.
Thu, Y. M., and A. Richmond. 2010. NF-kappaB inducing kinase: a key regulator in the immune system and in cancer. Cytokine Growth Factor Rev. 21:213-226.
Vallabhapurapu, S., and M. Karin. 2009. Regulation and function of NFkappaB transcription factors in the immune system. Annu. Rev. Immunol. 27:693-733.
Vallabhapurapu, S., et al. 2008. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIKdependent alternative NF-kappaB signaling. Nat. Immunol. 9:1364-1370.
Weih, F., and J. Caamano. 2003. Regulation of secondary lymphoid organ development by the nuclear factor-kappaB signal transduction pathway. Immunol. Rev. 195:91-105.
Weih, F., et al. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NFkappa B/Rel family. Cell 80:331-340.
Wu, L., et al. 1998. RelB is essential for the development of myeloid-related CD8alpha- dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells. Immunity 9:839-847.
Xiao, G., E. W. Harhaj, and S. C. Sun. 2001. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol. Cell 7:401-409.
Ye, H., Y. C. Park, M. Kreishman, E. Kieff, and H. Wu. 1999. The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol. Cell 4:321-330.
Yin, L., et al. 2001. Defective lymphotoxin-beta receptor-induced NFkappaB transcriptional activity in NIK-deficient mice. Science 291:2162-2165.
Zarnegar, B., S. Yamazaki, J. Q. He, and G. Cheng. 2008. Control of canonical NF-kappaB activation through the NIK-IKK complex pathway. Proc. Natl. Acad. Sci. U. S. A. 105:3503-3508.
Zarnegar, B. J., et al. 2008. Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat. Immunol. 9:1371-1378.
Zhou, H. J., et al. 2007. Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B-cell lymphoma. Blood 110:2121-2127.